Profile data is unavailable for this security.
About the company
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
- Revenue in EUR (TTM)60.61m
- Net income in EUR-67.87m
- Incorporated2014
- Employees526.00
- LocationBiocartis Group NVGeneraal de Wittelaan 11BMALINES (MECHELEN) 2800BelgiumBEL
- Phone+32 15632600
- Websitehttps://biocartis.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alpha Mos SA | 6.16m | -3.39m | 17.77m | 48.00 | -- | -- | -- | 2.89 | -0.3105 | -0.3105 | 0.5637 | -0.5066 | 0.8424 | 2.24 | 4.99 | 128,270.80 | -46.70 | -50.01 | -481.38 | -102.49 | 71.27 | 68.37 | -55.43 | -74.15 | 0.4423 | -10.76 | 11.30 | -- | 2.25 | 7.46 | -39.13 | -- | 7.59 | -- |
| Nexstim Oyj | 7.25m | -1.33m | 18.06m | 37.00 | -- | 6.37 | -- | 2.49 | -0.1956 | -0.1956 | 1.09 | 0.4192 | 0.7211 | 0.2708 | 3.76 | 195,845.70 | -13.21 | -26.77 | -20.24 | -43.90 | 96.38 | 92.11 | -18.32 | -38.38 | 1.42 | -12.60 | 0.61 | -- | -23.94 | 22.08 | -201.58 | -- | 19.51 | -- |
| Ondine Biomedical Inc | 544.88k | -12.67m | 18.37m | 43.00 | -- | 5.65 | -- | 33.71 | -0.056 | -0.056 | 0.0024 | 0.0124 | 0.0492 | 0.3584 | 5.54 | 10,896.51 | -114.33 | -- | -135.98 | -- | 49.00 | -- | -2,326.12 | -- | 1.93 | -- | 0.1961 | -- | -75.17 | -- | 61.32 | -- | -- | -- |
| Diagnostic Medical Systems SA | 42.15m | -9.76m | 18.46m | 147.00 | -- | 1.45 | -- | 0.4379 | -0.4982 | -0.2481 | 2.23 | 0.7023 | 0.8027 | 1.81 | 6.81 | 286,755.10 | -18.73 | -12.33 | -33.53 | -22.14 | 37.58 | 37.72 | -23.33 | -16.45 | 0.7105 | -3.52 | 0.5938 | -- | 19.51 | 11.62 | -106.30 | -- | -- | -- |
| Theraclion SA | 1.87m | -4.88m | 18.75m | 30.00 | -- | 2.77 | -- | 10.03 | -0.1362 | -0.1362 | 0.0504 | 0.1481 | 0.1021 | 0.282 | 1.23 | 66,785.00 | -26.65 | -40.08 | -35.36 | -59.96 | 54.21 | 52.19 | -260.94 | -276.13 | 2.50 | -56.17 | 0.2546 | -- | -16.58 | -12.66 | -32.02 | -- | 11.77 | -- |
| Acarix AB | 535.10k | -6.67m | 18.84m | 9.00 | -- | 4.23 | -- | 35.20 | -0.1642 | -0.1642 | 0.0132 | 0.0704 | 0.0943 | 0.1562 | 5.90 | -- | -117.61 | -66.93 | -150.10 | -77.12 | 84.87 | 79.42 | -1,247.20 | -1,483.68 | 3.95 | -272.12 | 0.00 | -- | 7.20 | 43.55 | -1.11 | -- | -- | -- |
| Mauna Kea Technologies SA | 10.48m | -3.73m | 25.01m | 67.00 | -- | -- | -- | 2.39 | -0.0578 | -0.0578 | 0.2126 | -0.2809 | 0.4905 | 2.31 | 2.45 | -- | -17.45 | -51.23 | -223.84 | -93.30 | 33.62 | 11.15 | -35.57 | -142.41 | 0.4287 | 4.29 | 2.38 | -- | 40.13 | 9.16 | 66.65 | -- | -21.16 | -- |
| Geratherm Medical AG | 25.03m | 1.04m | 25.05m | 188.00 | 15.29 | 1.09 | 7.53 | 1.00 | 0.3008 | 0.3008 | 5.43 | 4.21 | 0.6352 | 1.07 | 7.37 | 119,744.40 | 4.36 | 2.53 | 5.36 | 3.08 | 66.20 | 65.82 | 6.86 | 3.52 | 3.54 | 37.64 | 0.2596 | 164.98 | 7.98 | 4.21 | 737.25 | 8.53 | 12.77 | -20.42 |
| SpectraCure AB (publ) | 243.76k | -1.75m | 25.82m | 15.00 | -- | 2.32 | -- | 105.91 | -0.2104 | -0.2104 | 0.0293 | 1.34 | 0.0185 | -- | 17.28 | 189,533.30 | -13.31 | -12.75 | -14.35 | -13.62 | 435.56 | 195.30 | -718.99 | -494.40 | -- | -- | 0.0492 | -- | -3.30 | -- | 19.46 | -- | -- | -- |
| IMD International Medical Devices SpA | 38.01m | 2.22m | 26.82m | 116.00 | 11.84 | 1.22 | 8.70 | 0.7057 | 0.1284 | 0.1284 | 2.19 | 1.24 | -- | -- | -- | 327,653.90 | -- | -- | -- | -- | 27.27 | -- | 6.45 | -- | 1.59 | -- | 0.0638 | -- | -9.07 | -- | -24.35 | -- | -- | -- |
| Biocartis Group NV | 60.61m | -67.87m | 27.24m | 526.00 | -- | -- | -- | 0.4493 | -0.9993 | -0.9993 | 0.8171 | -0.5748 | 0.5548 | 1.56 | 3.31 | 115,231.90 | -62.13 | -34.35 | -84.71 | -40.38 | 51.40 | 40.84 | -111.97 | -145.71 | 1.60 | -2.55 | 1.55 | -- | 19.08 | 22.36 | 8.52 | -- | -14.81 | -- |
| Scandinavian Medical Solutions A/S | 25.64m | 1.64m | 27.88m | -- | 16.88 | 2.77 | 11.98 | 1.09 | 0.4479 | 0.4479 | 7.00 | 2.73 | 1.42 | 2.00 | 17.46 | -- | 9.05 | -- | 15.48 | -- | 25.83 | -- | 6.39 | -- | 0.4062 | 19.96 | 0.2776 | -- | 72.98 | -- | 7.49 | -- | -- | -- |
| Seyitler Kimya Sanayi AS | 4.07m | 1.07m | 28.65m | 63.00 | 26.80 | 6.09 | 24.93 | 7.03 | 0.3709 | 0.3709 | 1.41 | 1.63 | 0.714 | 1.73 | 7.01 | 1,836,392.00 | 18.73 | 36.20 | 22.35 | 44.02 | 38.12 | 39.86 | 26.23 | 43.89 | 3.38 | -- | 0.1319 | 0.00 | 84.40 | 45.46 | 193.51 | 107.12 | 30.39 | -- |
| Micropos Medical AB (publ) | 140.44k | -2.02m | 30.87m | 4.00 | -- | 38.77 | -- | 219.82 | -0.1663 | -0.1663 | 0.0117 | 0.0611 | 0.0606 | 0.0538 | 1.46 | -- | -87.07 | -64.24 | -115.32 | -82.27 | 86.75 | 114.76 | -1,437.12 | -767.58 | 1.15 | -- | 0.0429 | -- | 50.24 | 5.94 | -26.57 | -- | -- | -- |
| Boule Diagnostics AB | 48.99m | 2.15m | 33.23m | 228.00 | 15.67 | 0.8157 | 7.40 | 0.6783 | 0.6368 | 0.6368 | 14.64 | 12.23 | 0.7542 | 4.67 | 3.84 | 2,505,829.00 | 3.28 | 1.67 | 4.48 | 2.40 | 43.69 | 43.50 | 4.35 | 2.04 | 1.07 | 4.27 | 0.2591 | 42.24 | 4.24 | 6.13 | 96.24 | -9.45 | -9.74 | -- |
| Karolinska Development AB | 166.08k | 2.88m | 35.74m | 8.00 | 12.51 | 0.3371 | 12.09 | 215.18 | 0.1245 | 0.1245 | 0.0072 | 4.62 | 0.0016 | -- | 1.66 | 242,125.00 | 2.71 | 3.37 | 2.73 | 3.83 | -- | -- | 1,734.95 | 1,466.36 | -- | -- | 0.0023 | 0.00 | -12.43 | -8.10 | 106.11 | -29.31 | -- | -- |
Data as of Sep 22 2023. Currency figures normalised to Biocartis Group NV's reporting currency: Euro EUR
19.29%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Invesco Advisers, Inc.as of 31 Dec 2022 | 9.24m | 9.84% |
| Heights Capital Management, Inc.as of 31 Dec 2022 | 4.60m | 4.90% |
| Credit Suisse Asset Management (Schweiz) AGas of 31 Jan 2024 | 4.00m | 4.26% |
| Tocqueville Asset Management LPas of 29 May 2020 | 180.83k | 0.19% |
| ING Luxembourg SA (Private Banking)as of 31 Dec 2023 | 63.57k | 0.07% |
| Dimensional Fund Advisors LPas of 31 Jan 2024 | 20.30k | 0.02% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 3.16k | 0.00% |
| OFI Invest Asset Management SAas of 31 Dec 2022 | 0.00 | 0.00% |
More ▼
Data from 31 Dec 2023 - 02 May 2024Source: FactSet Research Systems Inc.
